Beta-Lactamase DataBase (BLDB): Structure and Function
Beta-Lactamase DataBase
Beta-Lactamase DataBase - Structure and Function Home Enzymes Structures Mutants Kinetics BLAST
Beta-Lactamase DataBase

Sequence alignment for the OXA-211-like beta-lactamase family

OXA-211
........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.....
MKTLQLALIALITTFGSACTTI-PPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATSEKVYFALNMHMKTGISASVREQLVKQSLTALGII
OXA-212.....SG...............-S........Q.......................V....S...............I...................................T.....................................................................................A................................A.....S.G.................................. 95.62 %
OXA-280......G..V..........I.RS..I......E...........................................................................N...................................Q..............................................................................................G.................................. 96.36 %
OXA-281.....FG...............-S..........................................................................R..............................................Q...............................................E..............................................G.........Q..................IT.... 96.35 %
OXA-309......................-S..........................................................................R..........................................V...Q......................................................................................A.....S.G..A......Q........................ 96.72 %
OXA-333..N...G..V............-S........QH............N.....................................I............................T..........I....................Q..........................................I.....................A..E..........................G.................................. 94.53 %
OXA-334...V..C..V............-S........QH...T........N...................................................R.............T............................V...Q......................................................................................A.....S.G..A......Q........................ 93.80 %
OXA-373......................-S.......................................R...........A.....................................................................Q..............................................................................................G.................................. 98.18 %
OXA-498......G...............-N........Q............................................................................N...................................Q...........K...............................K.........A..........S...........................S.G..................A............... 95.62 %
OXA-643..N...G..V............-S........Q............................................................Y.....................................................................................I...................A........................................G..................E............... 96.35 %
OXA-644..N...G..V............-S........Q.................................................................................................................................................................................................................................................. 98.18 %
OXA-645..N...G...............-S........Q..............................R...........A.....................................................................Q...........R...................................E..............................................G.........Q........................ 95.99 %
OXA-650..N...G...............-N......................N..................................................................................................Q..............................I............K.........A........................................GA........Q........................ 95.99 %
OXA-651.....FG...............-S.......................................R...........A.....................................................................Q..............................................................................................G.................................. 97.45 %
OXA-652..N...G..V............-S........QH..........................Y....................................................................................Q...............................................E..............................................G.........Q........................ 95.99 %
OXA-662.....FGF.......S......-S........Q................................................................................................................Q......R..............................................A...L....................................G.................................. 95.99 %
OXA-1044.....FG...............-S........Q..................................................................................................................................................I...................A........................................G..................E............... 97.08 %
OXA-1419...V..C..V............-N........QH...T........N...................................................R.............T............................V...Q......................................................................................A.....S.G..A......Q........................ 93.80 %
D-OXA-211-like phylogenetic tree

Last updated: April 06, 2026.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since March 29th, 2025)